Stanford researchers have developed an AI-powered "virtual scientist" capable of designing drug and vaccine candidates, marking a leap forward in biomedical research.
AstraZeneca CEO Pascal Soriot spoke to Antonello Guerrera about the ongoing vaccine feud - with the Commission receiving 60% less than expected, raising tense questions about why.
Prime Minister Boris Johnson announced that he had done "everything possible" to prevent 100,000 COVID deaths, as the UK witnesses 50,099 fatalities in the space of 79 days.
New vaccine data from Israel suggests that the double-dose of Pfizer is performing at the expected rate of 95% efficiency - with the possibility that it is performing even better than that being further investigated.
In response to the AstraZeneca feud, EU officials are creating a "transparency mechanism" for vaccine exports - which would indirectly hold companies accountable for fulfilling their agreed contracts.
The company announced that their current vaccine can handle the South African COVID mutation - with plans to create an "additional booster dose" to see if they can create specific protections against emerging variants.
The UK will offer its world-leading genomics expertise to identify new variants of the COVID-19 virus to countries who do not have the resources to do so.
Researchers are looking into Twitter whistle-blowers who raised concerns about suspicious 'pneumonia' cases, one month before the Chinese Government announced the existence of COVID-19.
Tomorrow (26 January) the COVID 'O' meeting is expected to be a moment of decision-making about border policy, as the more infectious South African and Brazilian COVID mutations continue to circulate.
Romy Rawlings, Commercial Director at Vestre Ltd, discusses how COVID-19 has acted as a catalyst for transforming urban spaces, and why introducing parklets could be the way forward.
EU leaders are investigating why AstraZeneca are not following through with the pre-agreed number of vaccines for the Member States - taking a 60% cut to the expected amount.
Data from Queen Mary University of London suggests that Asian COVID patients are 1.5 times as likely to die as white patients - with Black patients 1.3 times more likely to die.
Professor Herb Sewell, expert in immunology, wrote that the UK Government should not rely on one dose of the vaccine - suggesting that the diluted vaccine could encourage mutations to evolve.
